Artificial Intelligence in Drug Design



April 11, 2019

  • Share
  • Dr Ola Engkvist, Section Head, AstraZeneca, discusses how AI is being applied to drug design and the challenges associated with this approach. He also shares his insights on the future of AI in drug discovery.

    Drug DiscoveryInformatics

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.